Anixa Biosciences (NASDAQ:ANIX) Stock

ANIXA BIOSCIENCES INC

Anixa Biosciences

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Anixa Biosciences Inc

News

Collective Mining Reveals Plans For An Expanded Drill Program Following The Successful Completion Of Its Recent Financing For C$63.4M

Trilogy Metals Reports Q1 Results: Reports Net Loss Of $3.6M, Flat YoY, Exits Quarter With Cash And Equivalents Worth $25.2M

In the lead-up to &#8216;Liberation Day&#8217;, car dealerships in the US are seeing a spike in footfalls, as consumers race to book their new vehicles to avoid the post-tariff sticker shock that, according to some estimates, could <a href="https://benzinga.com/markets/25/03/44556198/tesla-bull-says-there-are-no-winners-with-trumps-auto-tariffs-calls-it-pure-chaos-for-global-supply-chains">reach as high as $10,000 to $15,000</a> even for mid-range cars.
What Happened: The looming 25% tariffs on all car imports to the US is set to become a reality within a few short hours, and it&#8217;s not just on the cars that are imported, but also those that are made in the US, but use imported parts. Since there is no such thing as an &#8216;All-American Car,&#8217; pretty much every make and model will see prices spike in the coming days.
See More: <a href="https://www.benzinga.com/markets/equities/25/04/44578839/trumps-25-tariff-on-imported-vehicles-could-shatter-detroits-auto-economy-warns-business-leaders-it-will-hurt-hardworking-americans">Trump&#8217;s 25% Tariff On Imported Vehicles Could Shatter Detroit&#8217;s Auto Economy, Warns Business Leaders: &#8216;It Will Hurt Hardworking Americans&#8217;</a>
Erin Keating, an analyst at Cox Automotive, said in a note that after this spike, which will last several days, auto sales will crater for the next several months. Both used and new car prices will increase, and certain models will be eliminated from American markets.
Keating further adds, &#8220;We have seen this movie before. During COVID, supply became constrained, costs skyrocketed. While the increase in prices this time may be for completely different reasons, it still stands to reason that the market will not bear another significant increase,&#8221; highlighting the risks these tariffs pose to the auto industry.
Why It Matters: As a result, car makers and dealerships are expected to have a good first quarter, but that&#8217;s not necessarily the case for Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), which is set to report its deliveries during the quarter on Wednesday.
Analysts expect the company to report its worst quarterly growth in years with just under 410,000 deliveries, up by a mere 5% from the prior year. This was expected as the brand took a nosedive across several key markets in recent months, in response to Elon Musk&#8217;s increasing political involvement.
Tariffs are set to <a href="https://in.benzinga.com/25/03/44507598/elon-musk-warns-of-significant-impact-on-tesla-due-to-trumps-auto-tariffs-the-cost-impact-is-not-trivial">hurt Tesla especially hard</a> since analysts estimate that they would add as much as $12,000 to the prices of most current EV models.
As you can expect, Tesla isn&#8217;t doing too well with all these issues, and according to Benzinga&#8217;s Edge Rankings, the stock is unfavorable in short, medium, and long-term. To see how the EV giant compares with its peers and competitors, <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">check out Benzinga Edge Pro</a>.
<figure class="wp-block-image aligncenter size-large"><img loading="lazy" decoding="async" width="1024" height="168" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02061119/Screenshot-2025-04-02-at-3.37.04-PM-1024x168.png" alt="" class="wp-image-852942" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02061119/Screenshot-2025-04-02-at-3.37.04-PM-1024x168.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02061119/Screenshot-2025-04-02-at-3.37.04-PM-300x49.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02061119/Screenshot-2025-04-02-at-3.37.04-PM-768x126.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02061119/Screenshot-2025-04-02-at-3.37.04-PM.png 1418w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/25/03/44522387/japanese-automakers-face-29-billion-tariff-hit-nissan-mazda-subaru-most-at-risk-says-analyst">Japanese Automakers Face $29 Billion Tariff Hit, Nissan, Mazda, Subaru Most At Risk, Says Analyst</a></li>
</ul>
Photo courtesy: Shutterstock

Government

Tech

TSLA

US Car Buyers Throng Dealerships As Trump's Tariff Threat Looms Over Prices

Franklin Covey Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FC#NYSE">FC</a>) will release its second-quarter financial results after the <a href="https://www.benzinga.com/quote/FC/earnings">closing bell on Wednesday, April 2</a>.
Analysts expect the Salt Lake City, Utah-based company to report a quarterly loss at 6 cents per share, versus a year-ago profit of 19 cents per share. Franklin Covey projects quarterly revenue of $62.65 million, compared to $61.34 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 8, Franklin Covey posted downbeat results for the first quarter.
Franklin Covey shares rose 1.4% to close at $28.00 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/FC/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Barrington Research analyst Alexander Paris maintained an Outperform rating with a price target of $45 on March 21, 2025. This analyst has an accuracy rate of 82%.</li>
<li>Roth MKM analyst Jeff Martin reiterated a Buy rating with a price target of $50 on June 27, 2024. This analyst has an accuracy rate of 70%.</li>
</ul>
Considering buying FC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="580" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02030522/image-15-1024x580.png" alt="" class="wp-image-852608" style="width:569px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02030522/image-15-1024x580.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02030522/image-15-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02030522/image-15-768x435.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02030522/image-15.png 1107w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44584246/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo via Shutterstock

Earnings

Price Target

Markets

Analyst Ratings

Trading Ideas

Franklin Covey Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Guidance

Health Care

General

ANGO

AngioDynamics Expects 2025 Adjusted EPS Loss Of $(0.31)-$(0.34) Compared To Prior Guidance Of $(0.34)-$(0.38) And Consensus Of $(0.37)

Phoenix Motor And InductEV Unveil World-First Wireless Charging For Medium-Duty Electric Shuttle Buses

MBLY

Mobileye Picks Valens' VA7000 MIPI A-PHY Chipsets For Automated And Autonomous Driving Projects

Fiscal Year 2025 Financial Guidance
For fiscal year 2025:
<ul>
<li>The Company now expects net sales to be in the range of $285 to $288 million, up from previously issued guidance of $282 to $288 million, representing growth between 5.3% to 6.4% over fiscal 2024 pro forma revenue of $270.7 million.</li>
<li>The Company now expects Med Tech net sales to grow in the range of 14% to 16%, an increase from prior guidance of 12% to 15%.</li>
<li>The Company continues to expect Med Device net sales to be flat.</li>
<li>The Company now expects Gross Margin to be approximately 53% to 54%, an increase from prior guidance of 52% to 53%.</li>
<li>The Company now expects Adjusted EBITDA to be in the range of $4.0 to $5.0 million, an increase from prior guidance of $1.0 to $3.0 million, and compared to a pro forma Adjusted EBITDA loss of $3.2 million in fiscal 2024. &nbsp;</li>
</ul>
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Guidance Metric</td>
<td colspan="1" rowspan="1">Guidance Action</td>
<td colspan="1" rowspan="1">
Current Guidance
(As of Apr. 2, 2025)
</td>
<td colspan="1" rowspan="1">
Previous Guidance
(Issued on Jan. 8, 2025)
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Sales</td>
<td colspan="1" rowspan="1">Increased</td>
<td colspan="1" rowspan="1">$285 - $288 million</td>
<td colspan="1" rowspan="1">$282 - $288 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Med Tech Net Sales Growth</td>
<td colspan="1" rowspan="1">Increased</td>
<td colspan="1" rowspan="1">14 - 16%</td>
<td colspan="1" rowspan="1">12 - 15%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Med Device Net Sales Growth</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Flat (unchanged)</td>
<td colspan="1" rowspan="1">Flat</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gross Margin</td>
<td colspan="1" rowspan="1">Increased</td>
<td colspan="1" rowspan="1">53 - 54%</td>
<td colspan="1" rowspan="1">52 - 53%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">Increased</td>
<td colspan="1" rowspan="1">$4.0 - $5.0 million</td>
<td colspan="1" rowspan="1">$1.0 - $3.0 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EPS</td>
<td colspan="1" rowspan="1">Increased</td>
<td colspan="1" rowspan="1">($0.31) - ($0.34)</td>
<td colspan="1" rowspan="1">($0.34) - ($0.38)</td>
</tr>
</tbody>
</table>
</figure>

AngioDynamics Expects 2025 Net Sales Of $285M-$288M Compared To Prior Guidance Of $282M-$288M And Consensus Of $284.91M

Enovis also reiterated its expectations for first quarter revenues to be in the range of $555 to $563 million and adjusted EBITDA in the range of $97 to $100 million.&nbsp;

ENOV

Enovis Appoints Damien McDonald as CEO, Effective May 12 2025, Following Matt Trerotola's Retirement

Michael Quartieri, Chairman of the Company's Board of Directors and Chief Executive Officer, will serve as the Interim Chief Financial Officer until a replacement has been identified and appointed.
Also on March 31, 2025, the Company provided notice of termination to Brandy Treadway, Chief Legal Counsel of the Company, effective as of April 2, 2025
 &nbsp;

Management

RMBL

RumbleOn Provided Notice Of Termination To CFO Tiffany Kice, Effective As Of April 2, 2025 - Filing

AngioDynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.13) by 123.08 percent. This is a 118.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $72.00 million which beat the analyst consensus estimate of $70.30 million by 2.42 percent. This is a 4.23 percent decrease over sales of $75.18 million the same period last year.

Earnings Beats

AngioDynamics Q3 2025 Adj EPS $0.03 May Not Be Comparable To $(0.13) Estimate, Sales $72.00M Beat $70.30M Estimate

Since March of 2021, Sentinum has mined approximately 3,061 Bitcoin.&nbsp;

GPUS

Hyperscale Data Says Subsidiary Sentinum Mined Approximately 56 Bitcoin From January To March 2025

Anthony Scaramucci, an influential cryptocurrency advocate and founder of investment firm SkyBridge Capital, has alternated between supporting President Donald Trump's pro-cryptocurrency pivot and warning of the potential pitfalls of some of his decisions.
What happened: Scaramucci, who served as the White House Communications Director for a brief 11-day stint during Trump&#8217;s previous presidency, has evolved into a <a href="https://in.benzinga.com/news/25/03/44211446/anthony-scaramucci-slams-donald-trump-hes-going-to-put-us-into-a-recession-frankly">vocal critic</a> of the president on matters such as tariffs and economic growth.
That said, Scaramucci hasn't hesitated in giving credit to Trump for some of the latter's cryptocurrency policies.
At the peak of the presidential campaign last year, Scaramucci praised <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40916521/anthony-scaramucci-calls-for-bipartisan-crypto-regulation-applauds-donald-trump-for-coming">Trump for moving the needle on digital asset regulation</a> and forcing a bipartisan conversation.&nbsp;
"I will applaud him for coming towards the industry," Scaramucci said about Trump.&nbsp;
Scaramucci has maintained that he is not a single-issue voter, and while he respects Trump and the Republicans&#8217; efforts to push Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) to the forefront, he is aware of the risks associated with Trump&#8217;s presidency.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Just to be clear: I am a bitcoiner and I applaud the policies decisions that the republicans are making to help the industry. I agree with every single thing that Pres Trump said related to bitcoin. Moreover, I praised him from the stage yesterday on forcing the issue and…
&mdash; Anthony Scaramucci (@Scaramucci) <a href="https://twitter.com/Scaramucci/status/1817366483036463470?ref_src=twsrc%5Etfw">July 28, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Later, when Trump assumed office and delivered on the promise of establishing a Strategic Bitcoin Reserve, the former White House executive lauded the decision, saying it would be beneficial for the U.S.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We believe in a United States Strategic <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> Reserve not because it will help Bitcoin, but because it will help the United States.
&mdash; Anthony Scaramucci (@Scaramucci) <a href="https://twitter.com/Scaramucci/status/1899155923546898449?ref_src=twsrc%5Etfw">March 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Scaramucci also described the administration's plans to buy Bitcoin through revenue-neutral means rather than relying on taxpayer funds as a <a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44249696/anthony-scaramucci-says-bitcoin-is-digital-store-of-value-and-the-us-should-own-it">pragmatic and politically savvy move</a>.
The former Trump aide <a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44393145/anthony-scaramucci-says-trump-administration-has-smarter-people-involved-with-crypto-regulation">acknowledged</a> that the current administration has "smarter" people involved in formulating cryptocurrency regulation&nbsp;
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/03/44487309/jim-cramer-applauds-gamestop-for-acting-on-his-bitcoin-ploy-as-apex-crypto-barely-moves-after-his-remark">Jim Cramer Applauds GameStop For Acting On His &#8216;Bitcoin Ploy,&#8217; CEO Ryan Cohen Can&#8217;t Help But React</a>
However, Scaramucci has been unforgiving when it comes to criticism.&nbsp;
He deemed the launch of the Official Trump (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>) meme coin as <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43076714/scaramucci-criticizes-donald-trumps-meme-coin-launch-idi-amin-level-corruption">"Idi Amin-level corruption"</a> and a potential "mirage" for the cryptocurrency industry's hopes.
More recently, Scaramucci described Trump&#8217;s post, where the POTUS called his memecoin the <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44451586/trump-meme-coin-spikes-retreats-after-potus-takes-to-truth-social-for-greatest-of-them-all-post-whale-takes-losses">&#8220;greatest of them all,&#8221;</a> a &#8220;pump&#8221; attempt. &#8220;The jig is up,&#8221; he added.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">President Trump posted on Truth Social last night in an attempt to "pump" his <a href="https://twitter.com/search?q=%24TRUMP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TRUMP</a> memecoin (yes that's a real sentence that many have normalized). The result has been an acceleration of the "dump," now down 70% from its peak. The jig is up. <a href="https://t.co/YF8U3D6tum">pic.twitter.com/YF8U3D6tum</a>
&mdash; Anthony Scaramucci (@Scaramucci) <a href="https://twitter.com/Scaramucci/status/1885719486906376421?ref_src=twsrc%5Etfw">February 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Moreover, he joined Peter Schiff in questioning Trump's posts from his Truth Social account announcing a strategic cryptocurrency reserve. The timing of the <a href="https://in.benzinga.com/25/03/44100165/peter-schiff-anthony-scaramucci-question-trumps-crypto-reserve-announcements-seek-congressional-inquiry">posts had stoked suspicions</a> of market manipulation and insider trading in some circles.
One could argue that Scaramucci offers a nuanced perspective that avoids one-sided cheerleading or criticism. He declined Benzinga&#8217;s request for comment due to his travel commitments.
Scaramucci previously revealed that a little over 55% of his net wealth is tied up in Bitcoin in addition to having a significant chunk of Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) in his portfolio.
Image via Shutterstock
<ul>
<li><a href="https://www.benzinga.com/25/03/44486921/xrp-outshines-bitcoin-ethereum-with-17-ytd-gains-as-trump">XRP Has Outshone Bitcoin, Ethereum This Year With Impressive 17% YTD Gains — Will It Reclaim The Third-Largest Crypto Spot?</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Politics

$BTC

$SOL

$TRUMP

Anthony Scaramucci Hates It When Trump Pumps His Own Coin, But Loves The President's Bitcoin Moves — This Complex Crypto Relationship Decoded

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) short interest has increased by over 21% during its current reporting period, making it the fourth most shorted stock in the U.S. market currently.
What Happened: The short interest on the company led by Elon Musk has increased from 67.126 million to 81.331 million shares. About 2.9% of the company's publicly available shares were shorted as of the settlement date on March 14, having an effective date of March 25.
According to Nasdaq data, the short interest soared by 21.16% from the previous settlement date of Feb. 28.
The average daily trading volume during the latest period increased from 84.714 million to 125.16 million shares. The volume indicated that it would require approximately one day for the short sellers to cover their positions without significantly impacting the stock price.
While high short interest signals bearishness, an increase during the current report period indicates lower confidence. According to Beth Kindig, a tech analyst at I/O Fund, this increase makes its notional short interest of 81.331 million shares, the fourth-most currently after Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>).
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Tesla's <a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> short interest has risen to 81M shares, per S3 partners, making its notional short interest the fourth-largest after Nvidia <a href="https://twitter.com/search?q=%24NVDA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$NVDA</a>, Microsoft <a href="https://twitter.com/search?q=%24MSFT&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$MSFT</a>, and Apple <a href="https://twitter.com/search?q=%24AAPL&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$AAPL</a>.
&mdash; Beth Kindig (@Beth_Kindig) <a href="https://twitter.com/Beth_Kindig/status/1907119660358893992?ref_src=twsrc%5Etfw">April 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/04/44600269/mark-cuban-argues-ais-new-sht-will-drive-growth-not-deflation">Mark Cuban Dismisses Concerns of AI Causing Deflation, Calls It The &#8220;Greatest Growth And Productivity Engine Ever&#8221;</a>
<h3 class="wp-block-heading">Technical Analysis</h3>
The technical indicators painted a grim picture for the stock, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. As the stock closed at $268.46 apiece on Tuesday, its price trend remained weak. While it was above its 20-day simple moving average of $254.19, it trailed the eight, 50, and 200-day moving averages.
The relative strength index of 47.30 was in the neutral zone. The momentum indicator MACD indicated that the stock is in a bearish trend as the score of its MACD line was -11.6, showing that its 12-period exponential moving average is below the 26-period EMA.
However, the histogram has a positive number of 6.65, meaning that the MACD line is rising and getting closer to the signal line. This signaled a bullish sign within a bearish trend, depicting that the bearish momentum is decreasing.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034147/Tesla-Tech-chart-1024x576.png" alt="" class="wp-image-852684" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034147/Tesla-Tech-chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034147/Tesla-Tech-chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034147/Tesla-Tech-chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034147/Tesla-Tech-chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034147/Tesla-Tech-chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Price Action: Shares of Tesla were trading 1.37% lower in premarket on Wednesday, while the Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), tracking the Nasdaq 100 index, was down by 0.46%.
The stock has fallen by 29.22% on a year-to-date basis, whereas it was up 61.11% over the last year.
Benzinga Edge Stock Rankings indicate Tesla has negative price trends over the short, long, and medium term. Its momentum ranking was solid at the 90.20th percentile, but its value ranking was weaker. Further fundamental details and the quality and growth <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">rankings are available here</a>.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/report/TSLA"><img loading="lazy" decoding="async" width="796" height="130" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034235/Tesla-Edge-new.png" alt="" class="wp-image-852688" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034235/Tesla-Edge-new.png 796w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034235/Tesla-Edge-new-300x49.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034235/Tesla-Edge-new-768x125.png 768w" sizes="(max-width: 796px) 100vw, 796px" /></a></figure>
<a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">Benzinga&#8217;s analysis of 29 analysts</a> shows a consensus &#8220;hold&#8221; rating for the stock, with an average price target of $309.55, ranging from $24.86 to $550. Recent ratings from Stifel, Deutsche Bank, and Wedbush average $450, suggesting a 67.86% potential upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/TSLA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="385" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034257/Tesla-ANR-new-latest-1024x385.png" alt="" class="wp-image-852689" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034257/Tesla-ANR-new-latest-1024x385.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034257/Tesla-ANR-new-latest-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034257/Tesla-ANR-new-latest-768x289.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02034257/Tesla-ANR-new-latest.png 1063w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/44580978/goldman-sachs-warns-us-stocks-are-at-risk-of-further-declines-but-policy-pivot-from-trump-or-fed-cou" target="_blank" rel="noreferrer noopener">Goldman Sachs Warns US Stocks ‘Are At Risk Of Further Declines,' But Policy Pivot From Trump Or Fed Could Stoke Recovery</a></li>
</ul>
Photo courtesy: Shutterstock

Analyst Color

Equities

Market Summary

Broad U.S. Equity ETFs

Futures

Technicals

ETFs

AAPL

MSFT

NVDA

Tesla Short Interest Soars To 21.16%, Making It 4th Most Shorted Stock Currently: Here's What Its Charts Indicate

Biotech

Financing

Offerings

EWTX

Edgewise Therapeutics Priced An Underwritten Offering Of 9.94M Shares At $20.13 Per Share. Edgewise Anticipates Gross Proceeds From The Offering To Be Approximately $200M

Joelle Pineau, the Vice President of AI research at Meta Platforms Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), has decided to step down and leave the company in May. 
What Happened: Pineau announced her departure via a Facebook post on Tuesday. She has been with&nbsp;Meta since May 2017, overseeing the company&#8217;s Fundamental AI Research lab&nbsp;(Fair), led by Yann LeCun.
During her tenure, Pineau and her team have developed numerous projects that have become integral to Meta&#8217;s operations. These include&nbsp;PyTorch, FAISS, Roberta, Dino, Llama,&nbsp;SAM, Codegen, and Audiobox.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="689" height="343" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02061342/image-23.png" alt="" class="wp-image-852949" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02061342/image-23.png 689w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02061342/image-23-300x149.png 300w" sizes="(max-width: 689px) 100vw, 689px" /></figure>
Pineau expressed her admiration and gratitude for her managers at Meta, including&nbsp;Michael Schroepfer, Jerome Pesenti, Michael&nbsp;Abrash and Chris Cox. She also acknowledged her team and collaborators, stating that they have been instrumental in charting the future of AI.
See Also: <a href="https://benzinga.com/markets/25/04/44601197/massive-data-breach-at-elon-musks-x-reportedly-exposes-data-of-millions-of-accounts-by-far-the-largest-social-media-breach-ever" target="_blank" rel="noreferrer noopener">Massive Data Breach At Elon Musk&#8217;s X Reportedly Exposes Over 200 Million Users' Email IDs: &#8216;By Far The Largest Social Media Breach Ever&#8217;</a>
In an October interview with the Financial Times, Pineau shared, "Meta was the only [company] that had a commitment to open science and open research. And so I didn't bother interviewing anywhere else."
As Meta enters its next chapter, Pineau believes it&#8217;s time to make way for others to continue the work. Her last day at Meta will be May 30, after which she plans to take some time to reflect before embarking on a new adventure.
Why It Matters: Pineau&#8217;s departure comes at a critical time for Meta, as the company is significantly increasing its investment in AI, with plans to spend $65 billion on AI infrastructure in 2025. This move is part of CEO Mark Zuckerberg&#8216;s strategy to prioritize AI at Meta, with projects like Llama, Meta&#8217;s open-source large language model, at the forefront of this initiative.
Zuckerberg&#8217;s goal is to make Llama the industry standard worldwide and to expand the reach of Meta&#8217;s AI chatbot across Facebook, Instagram, and WhatsApp to a billion users this year. As of December, 600 million users accessed Meta AI each month.
Pineau&#8217;s exit could pose challenges for Meta as it competes with rivals like OpenAI, Anthropic, and Elon Musk&#8216;s xAI. Furthermore, last year, Meta reportedly reorganized the company to have its AI research unit report to the company's chief product officer, Chris Cox, which could also be impacted by Pineau&#8217;s departure.
<ul>
<li>Read Next: <a href="https://benzinga.com/25/04/44600545/do-you-know-trumps-travel-ban-might-hit-this-bitcoin-friendly-nation-its-not-el-salvador" target="_blank" rel="noreferrer noopener">Trump Travel Ban Might Hit This Bitcoin-Friendly Country And No It&#8217;s Not El Salvador</a></li>
</ul>
Image via Shutterstock

Meta's AI Research Head Announces Departure After 7 Years As Mark Zuckerberg Doubles Down On AI Investments

<a href="https://www.bloomberg.com/news/articles/2025-04-02/china-restricts-companies-from-investing-in-us-as-tensions-rise" title="https://www.bloomberg.com/news/articles/2025-04-02/china-restricts-companies-from-investing-in-us-as-tensions-rise">https://www.bloomberg.com/news/articles/2025-04-02/china-restricts-companies-from-investing-in-us-as-tensions-rise</a>

Macro Economic Events

Economics

Bloomberg Reported China Restricts Companies From Investing In US

This increases Xing Jin's total beneficial ownership to 24.9 % of the Company's outstanding shares. The ADSs were purchased at a price of $0.9 per ADS, for a total aggregate purchase price of $4.09 million.
Xing Jin, the Company's chairman of the board of directors, chief executive officer, and controlling shareholder, purchased a total of 4.54 million American depositary shares ("ADSs") representing 3.496 million Class A ordinary shares of the Company&nbsp;in the open market&nbsp;in accordance with Rule 10b-18 of the Securities Exchange Act of 1934, as amended, using personal funds.

So-Young Reveals Share Purchase By Controlling Shareholder Xing Jin, Increasing His Total Beneficial Ownership To 24.9 %

ENSG

Ensign Group Adds Five Facilities Across California And Washington, Grows Portfolio To 343 Operations

Hedge fund manager Ray Dalio&#8217;s Bridgewater Associates has <a href="https://benzinga.com/25/03/44230866/state-street-and-bridgewater-bring-hedge-fund-strategy-to-etfs-with-allw">launched an exchange-traded fund (ETF)</a> inspired by its famous &#8216;All-Weather&#8217; strategy. 
What Happened: In partnership with State Street Global Advisors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>), leading hedge fund, Bridgewater Associates has unveiled its popular all-weather portfolio strategy as an ETF, the SPDR Bridgewater All Weather ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLW#NASDAQ">ALLW</a>).
The strategy is designed to deliver consistent returns for investors across economic environments and market cycles. It uses a risk parity approach to investment, where allocations to different assets are based on their levels of volatility.
See More: <a href="https://www.benzinga.com/markets/23/11/35900803/the-downsides-of-diversification">Billionaire Investor Ray Dalio Warns Of Looming Debt Crisis And Shifting Global Order Amid Trump&#8217;s Hardline Trade Policies</a>
Created in 1996 by Ray Dalio himself, the strategy involves allocating 30% of assets into equities, 40% into long-term US Treasury bonds, 15% into intermediate-term US Treasury Bonds, 7.5% into gold, and 7.5% into commodities other than gold. During its three decades of existence, this strategy has generated a compounded annual growth of 7.5%.
While it has trailed the S&amp;P 500, which compounded at 9% during this period, it&#8217;s worth noting that this period involved the Asian Financial Crisis, the Dot-Com Bubble, the Great Recession, and COVID-19. The metric that truly matters with all of this is the max drawdown, which stands at 20.58%, as opposed to the S&amp;P 500&#8217;s 25%.
The entire <a href="https://www.benzinga.com/markets/23/11/35900803/the-downsides-of-diversification">&#8216;All-Weather&#8217; strategy</a> is set to be distributed across five separate ETFs, all managed by State Street Global. Each will feature certain variances to suit market conditions and investor preferences, but the broader goal remains resilience in the face of turmoil.
Why It Matters: The popular strategy was up until now only available for rich accredited investors or institutions who could invest a minimum of $500,000. With the launch of this ETF, however, retail investors can get in on this strategy for just $22, which is the current price of the fund. 
The ETF has a expense ratio of just 0.85%, compared to the standard 2% management fee and 20% performance fee that hedge funds often charge.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/04/44601574/warren-doubles-down-on-japan-another-yen-bond-blitz-amid-growing-us-market-volatility">Warren Doubles Down On Japan: Another Yen Bond Blitz Amid Growing US Market Volatility</a></li>
</ul>
Photo courtesy: Shutterstock

ALLW

Ray Dalio's Bridgewater Launches 'All-Weather' ETF, Bringing Decades-Old Investment Strategy To The Public

Press Releases

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

Small Cap

Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th

Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th

Comments

Anixa Biosciences

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL